marketnews

Breaking News: Hepion Pharmaceuticals’ Phase 2 ALTITUDE NASH Trial Successfully Meets Primary and Secondary Endpoints, Significantly Improving Liver Function and Multiple NASH Biomarkers

Breaking News: Hepion Pharmaceuticals’ Phase 2 ALTITUDE NASH Trial Successfully Meets Primary and Secondary Endpoints, Significantly Improving Liver Function and Multiple NASH Biomarkers Improvements in Liver Function and NASH Biomarkers In a groundbreaking development, Hepion Pharmaceuticals has announced that their Phase 2 ALTITUDE NASH trial has achieved both primary and secondary endpoints. This milestone marks…

Read More

Intapp Inc. to Take Part in Upcoming Investor Conference: A Must-Attend Event for Industry Leaders

PALO ALTO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Intapp (NASDAQ: INTA) to Attend J.P. Morgan 51st Annual Global Technology, Media, and Communications Conference What to Expect from Intapp’s Participation Intapp, a prominent cloud software provider for the professional and financial services sector, has confirmed its senior management’s attendance at the upcoming J.P. Morgan 51st…

Read More

Unpacking the G7 Leaders’ Statement on Economic Coercion: A Humorous and Quirky Guide

Unpacking the G7 Leaders’ Statement on Economic Coercion: A Humorous and Quirky Guide Description: (Reuters) – Leaders of the Group of Seven (G7) agreed on Saturday to establish an initiative to counter economic “coercion”, pledging to take steps to ensure that any actors attempting to “weaponise” economic dependence would fail and face consequences. The initiative,…

Read More

Unlocking Success: Aclarion’s Non-Convertible Debt Financing for Three Vital Catalysts

Unlocking Success: Aclarion’s Non-Convertible Debt Financing for Three Vital Catalysts Up to $2M Unsecured, Non-Convertible Bridge Debt With No Required Amortization Payments Financing Supports Execution of the 2023 Plan and the Achievement of Critical Milestones in Support of Definitive Growth Capital BROOMFIELD, CO, May 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Aclarion, Inc., (“Aclarion”…

Read More